A very high percentage of Prior Authorization (PA) requests are approved…but about 40% of these prescriptions are abandoned during the PA process, around 74.4 million prescriptions a year.

Valeant Pharmaceuticals International Inc. was sued by buyers of its drugs, who accused the Canadian company of racketeering by forcing them to pay exorbitant prices.

April 25, 2016 By Alex Keown, BioSpace.com Breaking News Staff     DUBLIN — John T. Hendrickson has been tapped as the new chief executive officer of Perrigo Company PLC (PRGO), after former CEO Joseph Papa left the company to helm rival Valeant Pharmaceuticals (VRX). Last week BioSpace (DHX) reported Papa was the favorite to […]

New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pick up their first refill and existing specialty patients […]

BASEL, Switzerland – Novartis AG (NVS) will pay $390 million to settle a civil lawsuit related to the kickback payments to specialty pharmacy companies that distributed the drugs Exjade and Myfortic, Novartis announced Friday. The settlement, which is between Novartis Pharmaceutical Corporation (NVS), a U.S. subsidiary of Novartis AG, will be paid to both the […]

LAVAL, Quebec – Embattled Valeant Pharmaceuticals International Inc. (VRX) is offering stock and cash incentives in an effort to keep key employees from jumping to another company, Reuters reported this morning. A Valeant spokesperson told Reuters that approximately 70 employees “below the executive level” have been offered incentives to stay with the company. It is […]

In recent days, the largest U.S. managers of private prescription drug benefits have cut off at least eight pharmacies that work closely with drugmakers, intensifying scrutiny of a system that helps inflate drug prices, officials at the benefit managers told Reuters. The terminations come from payers who together manage drug benefits for more than 100 […]

PALO Alto, Calif. – More questions have arisen about the leadership structure at Theranos, following a Forbes column questioning decisions over stock splits and how much of a say shareholders in the private company have regarding company direction. Forbes columnist Peter Cohan cites a 2013 letter to shareholders asking support for the creation of two […]

Drugstore chain Walgreens Boots Alliance Inc is willing to divest up to 1,000 stores to win regulatory approval for its acquisition of Rite Aid Corp, the Associated Press reported. Walgreens expects it will not have to sell more than 500 of its stores, AP said citing Walgreens. (bit.ly/1KVrkDa) Walgreens declined to comment. On October 27, […]

Valeant Pharmaceuticals International Inc sought to reassure doctors on Monday that the company’s decision to cut ties to a controversial specialty pharmacy would not disrupt doctors’ ability to prescribe the company’s drugs to patients.   In a letter to healthcare professionals seen by Reuters, Chief Executive Officer Michael Pearson said that Valeant would pay for […]